View More Recent Stories
-
Eight defensive growth stocks to own right now
-
RBC's biotech survey shows investors more bearish vs. last time
-
H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
-
Legend Biotech Corp. (LEGN) PT Raised to $70 at Scotiabank
-
BTIG Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
-
Legend Biotech Corp. (LEGN) PT Lowered to $67 at TD Cowen
-
Legend Biotech said to have received takeover approach, hired Centerview - source
-
H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
-
BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
-
Legend Biotech (LEGN) Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial
-
RBC Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
-
Piper Sandler Reiterates Overweight Rating on Legend Biotech Corp. (LEGN)
-
Truist Securities Starts Legend Biotech Corp. (LEGN) at Buy
-
Top pharma stocks to own in 2024 – Citi

